The author of today’s article believes that too many individual investors ignore analyst estimates. In contrast, believing strongly in the importance of Wall Street research, the author screened for low-priced stocks that “analysts have spent hours studying and determined…are deeply undervalued.” Specifically, each of the stocks highlighted are selling for less than $5 and are ones “analysts believe can gain at least 50% in the next year.” To see what these stocks are – including a Brazilian steel company, a small medical supply company, and a biotech company currently trading at less than $0.50 a share – as well as for the price targets of the analysts following these stocks and the author’s recommended action to take, CLICK HERE.